Proposal of the Board of Directors for the appropriation of the available profit

in CHF	2022	2021
Net profit/(loss) for the year	14’269’773	–497’618
Unallocated profit carried forward from previous year	4’045’272	–
Total available profit	18’315’045	–497’618
Appropriation from free reserves	5’000’000	25’000’000
Ordinary dividend	–20’457’417	–20’457’111
Balance carried forward	2’857’628	4’045’272

Dividend distribution per share CHF 0.01
Gross dividend	0.50	0.50
Withholding tax (35%)	–0.18	–0.18
Net dividend	0.32	0.32

Reserves from capital contribution	294’653’000	294’653’000
Allocation to free reserves	–	–
Balance carried forward	294’653’000	294’653’000

Free reserves	268’104’248	293’104’248
Allocation to balance carried forward	–5’000’000	–25’000’000
Balance carried forward	263’104’248	268’104’248

The Board of Directors proposes the payment of a dividend of CHF 0.50 per share to the Annual General Meeting on April 28, 2023. The company will not pay a dividend on treasury shares held by medmix Ltd or one of its subsidiaries.